The New York Times

Home/Tag: The New York Times

The Stash, Volume 48: Russell 3000 rebalancing sets stage for greater institutional ownership of cannabis names

RUSSELL 3000 REBALANCING SETS STAGE FOR GREATER INSTITUTIONAL OWNERSHIP OF CANNABIS NAMES We believe the inclusion of GrowGeneration Corp. (GRWG) and Akerna (KERN) in the Russell 3000 index is indicative of the rising interest of institutional investors in the cannabis space. GrowGeneration, the largest chain of stand-alone specialty hydroponic and organic garden centers in the U.S., [...]

2020-07-15T19:10:05+00:00June 19th, 2020|

The Stash, Volume 46: Market Share gains, profitability make Trulieve a standout cannabis name

MARKET SHARE GAINS, PROFITABILITY MAKE TRULIEVE A STANDOUT CANNABIS NAME Trulieve’s (TCNNF) continued market share gains validate our thesis that capital-efficient state leaders are best placed to emerge as winners in the U.S. cannabis market. Our analysis of data from the Florida Office of Medical Marijuana Use suggests that Trulieve’s dominance of Florida’s cannabis market continues [...]

2020-07-15T19:11:03+00:00June 3rd, 2020|

The Stash, Volume 42: The Second Coming of the Cannabis Bellwether

CANOPY GROWTH CORP (CGC): THE SECOND COMING OF THE CANNABIS BELLWETHER We believe Constellation Brands’ (STZ) purchase of an additional stake in Canopy Growth Corp. (CGC) reaffirms investors’ faith in the cannabis legalization story. On May 1, global beer, wine, and spirits major Constellation Brands exercised an aggregate of 18.8 million warrants to purchase additional shares [...]

2020-07-15T19:13:01+00:00May 13th, 2020|

The Stash, Volume 41: The two stocks best positioned to benefit from growing OK and OR cannabis markets

THE TWO STOCKS BEST POSITIONED TO BENEFIT FROM GROWING OK AND OR CANNABIS MARKETS In our Stash report last week, we discussed why Oklahoma (OK) and Oregon (OR) are well-positioned to benefit from cannabis’ essential industry status. This week, we highlight the two companies that are in a strong position in these markets and should be [...]

2020-07-15T19:13:35+00:00April 29th, 2020|

The Stash, Volume 38: Cannabis Legalization in 2020: A COVID-19 Casualty

CANNABIS LEGALIZATION IN 2020: A COVID-19 CASUALTY Cannabis legalization – key to the $50 billion+ illicit-to-legal value migration in the industry – is emerging as one of the casualties of the COVID-19 pandemic. In the last three weeks, we have discussed the impact that the spread of coronavirus is having on the cannabis industry, ranging from [...]

2020-04-08T15:44:35+00:00April 8th, 2020|

The Stash, Volume 37: Cannabis – The New Essential

CANNABIS: THE NEW ESSENTIAL Cannabis’ “essential” designation will drive sales higher even during the COVID-19 pandemic. We discussed in last week’s Stash report how cannabis sales saw a sharp surge in March as part of consumers’ stay-at-home strategy. These sales are likely to be boosted further by the classification of marijuana – especially medical marijuana – [...]

2020-04-01T16:44:50+00:00April 1st, 2020|

The Stash, Volume 31: The Valens Company – Extracting Value for Investors

THE VALENS COMPANY: EXTRACTING VALUE FOR INVESTORS The Valens Company (VLNCF) is one of the best cannabis extraction and testing names for investors to follow. Valens provides best-in-class proprietary services, including CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation, and white-label product development and manufacturing to leading Canadian and international cannabis brands. It has [...]

2020-03-30T14:00:46+00:00February 19th, 2020|
Go to Top